Down-regulation of tumor necrosis factor receptors by blockade of mitochondrial respiration.
We have studied the effect of blockade of mitochondrial respiration on the binding of human 125I-TNF alpha to L929 cell receptors. Specific TNF alpha binding was decreased to about 20-40% of controls by blocking mitochondrial respiration. This effect was dose- and time-related and was observed independently of the level at which the respiration was blocked (respiratory chain, proton backflow, ATPase, anaerobiosis). This blockade had no effect on the half-life of the specific TNF alpha binding, the internalization or degradation of TNF alpha-receptor complexes, or the number of TNF alpha-binding sites. Scatchard analysis of TNF alpha binding data indicated a 2-4-fold decrease in the affinity of these binding sites. These effects did not appear to be related to the protein kinase C activity or to reactive oxygen radicals, since they were not antagonized by pretreatment of cells with oxygen radical scavengers, deferoxamine, or inhibitors of protein kinase C. Decrease in TNF alpha binding capacity correlated significantly with cellular ATP content (r = 0.94; p < 0.01) and with the cytocidal activity of TNF alpha against L929 cells. These findings suggest that blockade of mitochondrial respiration down-regulates the binding of TNF alpha to cells, most likely by changing the affinity of receptors for this cytokine. This down-regulation may increase the resistance of cells to TNF alpha cytotoxicity.
Sánchez-Alcázar
J A
JA
Centro de Investigación, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain.
Hernández
I
I
De la Torre
M P
MP
García
I
I
Santiago
E
E
Muñoz-Yagüe
M T
MT
Solís-Herruzo
J A
JA
D019297:2,4-Dinitrophenol; D000693:Anaerobiosis; D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D015536:Down-Regulation; D016166:Free Radical Scavengers / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D007739:L Cells; D008314:Malonates / Q000494:pharmacology; D051379:Mice; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D009840:Oligomycins / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects*; D011190:Potassium Cyanide / Q000494:pharmacology; D018124:Receptors, Tumor Necrosis Factor / Q000187:drug effects / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D012402:Rotenone / Q000494:pharmacology; D012969:Sodium Fluoride / Q000494:pharmacology; D013804:Thenoyltrifluoroacetone / Q000494:pharmacology; D014475:Uncoupling Agents / Q000494:pharmacology*
D004140:Dinitrophenols; D016166:Free Radical Scavengers; D008314:Malonates; D009840:Oligomycins; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D014475:Uncoupling Agents; D012402:Rotenone; D013804:Thenoyltrifluoroacetone; D000968:Antimycin A; D012969:Sodium Fluoride; C030290:malonic acid; D011190:Potassium Cyanide; D019297:2,4-Dinitrophenol